Why Is BioCryst Pharmaceuticals (BCRX) The Stock Of The Day?

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

BioCryst Pharmaceuticals BCRX headquartered in Durham, North Carolina, operates in late-stage biotech research, focusing on medications for serious or rare diseases.

Why is BCRX Moving?

BCRX is moving after a recent announcement by the firm that it has designed trials for a blood disorder medication. Treating a particularly rare blood disorder puts BioCryst Pharma at the forefront of the industry, addressing a difficult issue in the medical world.

Where to Buy BioCryst Pharmaceuticals Stock

Use this list of brokers curated by Benzinga to invest in BCRX stock, other stocks and diversify your portfolio as much as possible. 
 

Stay Ahead of the Game on BCRX

Check out Benzinga Pro to gather all the information you need to stay ahead of the game on BCRX stock. You want to know everything there is to know about all your investments, study new investments and increase your net worth. You can do that using just one tool.

Data for BioCryst Pharmaceuticals as of July 15, 2021

Summary of BioCryst Pharmaceuticals as of July 15, 2021:

• Price Change: $15.630 to $15.98
• 52 Week Low: $3.30
• 52 Week High: $17.735
• Market Cap: $2.777B
• P/E Ratio: -
• Dividend Yield: -

Significant Dates for BioCryst Pharmaceuticals:

• Next Earnings Date: August 5, 2021
• Last Earnings Date: May 6, 2021 EPS of $-0.360
• Ex-Dividend Date: -
• Dividend Payment Date: -

Technical Data of BioCryst Pharmaceuticals as of July 15, 2021:

• RSI: 63.3093 ⮕ Bullish
• MACD: Signal Line (2.0924) MACD Over (-2.0924) ⮕ Bullish
• Bollinger Bands: Price ($15.98), 20-Day SMA ($16.0233), Lower Band ($8.8477), Upper Band ($18.4260) ⮕ Neutral

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.